Clinical Trials · NCT05760313
A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- AbbVie
- Enrollment
- 19
- Start date
- Apr 2023
- Locations
- 38 sites, 7 countries
- Primary endpoint
- Change From Baseline in Overall Spontaneous Bowel Movement (SBM) Frequency Rate (SBMs/Week) During the Study Intervention Period